ACCENTIA BIOPHARMACEUTICALS TO RAISE $ 8.2M IN EQUITY FINANCING

Accentia Biopharmaceuticals, Inc., on May 15, 2006, entered into definitive purchase agreements in a private placement of its common stock and warrants led by institutional investors totaling $8,235,000. The placement was priced at $5.00 per share and resulted in the issuance of 1,647,000 shares of common stock and warrants to purchase an additional 823,500 shares of common stock at an exercise price of $6.59 per share.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1592884)